for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Celsion Reports That Sufficient Events Have Been Reached For Second Interim Analysis Of Phase III Optima Study Of Thermodox In Primary Liver Cancer

April 15 (Reuters) - Celsion Corp:

* CELSION REPORTS THAT SUFFICIENT EVENTS HAVE BEEN REACHED FOR THE SECOND INTERIM ANALYSIS OF THE PHASE III OPTIMA STUDY OF THERMODOX® IN PRIMARY LIVER CANCER

* CELSION CORP - INDEPENDENT DATA MONITORING COMMITTEE IS EXPECTED TO MEET IN JULY TO CONDUCT SECOND INTERIM ANALYSIS

* CELSION CORP - EXPECTS TO ANNOUNCE IDMC RECOMMENDATIONS AS SOON AS POSSIBLE AFTER MEETING Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up